Tesmilifene in Combination With Docetaxel in the Treatment of Metastatic Breast Cancer

NCT00364195 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

33

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastatic Breast Cancer

Interventions

DRUG: Tesmilifene (YMB1002)

Sponsor

YM BioSciences